Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor agonist. This revolutionary approach holds significant potential for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide boosts insulin secretion and suppresses glucagon release, leading to improved glucose control. Clinical trials have demo